Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review

Cancer initiation and progression have been associated with dysregulated long non‐coding RNA (lncRNA) expression. However, the lncRNA expression profile in aggressive B‐cell non‐Hodgkin lymphoma (NHL) has not been comprehensively characterized. This systematic review aims to evaluate the role of lnc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cellular and molecular medicine Jg. 27; H. 14; S. 1928 - 1946
Hauptverfasser:	Khanmohammadi, Shaghayegh, Fallahtafti, Parisa
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley & Sons, Inc 01.07.2023 John Wiley and Sons Inc
Schlagworte:	Adult aggressive non‐Hodgkin lymphoma Apoptosis B-cell lymphoma biomarker Biomarkers Burkitt Lymphoma - drug therapy Burkitt's lymphoma Cell cycle Cell migration Cell proliferation Chemotherapy Cyclin-dependent kinases Diagnosis diffuse large B‐cell lymphoma Epigenetics Growth factors Humans Kinases Leukemia long non‐coding RNA Lymphocytes Lymphocytes B Lymphoma Lymphoma, Large B-Cell, Diffuse - diagnosis Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - genetics Lymphoma, Mantle-Cell Mantle cell lymphoma Non-coding RNA Non-Hodgkin's lymphoma non‐Hodgkin lymphomas Pathogenesis Prognosis Proteins Review Reviews RNA, Long Noncoding - genetics Systematic review Therapeutic applications Therapeutic targets non-Hodgkin lymphomas aggressive non-Hodgkin lymphoma mantle cell lymphoma long non-coding RNA diffuse large B-cell lymphoma biomarker Burkitt's lymphoma
ISSN:	1582-1838, 1582-4934, 1582-4934
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!